Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Gad B. Kletter"'
Autor:
Mirta Gryngarten, Erica A. Eugster, Karen O Klein, Bradley S. Miller, Matthew Benson, Gad B. Kletter, Nelly Mauras, Tala Dajani, Analia Freire
Publikováno v:
The Journal of Clinical Endocrinology and Metabolism
Context Gonadotropin-releasing hormone agonists (GnRHas) are standard of care for central precocious puberty (CPP). A 6-month subcutaneous injection has recently been approved by the Food and Drug Administration. Objective Determine efficacy, pharmac
Autor:
Eric Humphriss, George M. Bright, Huong Jil Nguyen, Douglas Rogers, Jerome A. Moore, David Ng, Gad B. Kletter, Wayne V. Moore, Bradley S. Miller, Jeffrey L. Cleland
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 101:1091-1097
Context: Somavaratan (VRS-317) is a long-acting form of recombinant human GH under development for children and adults with GH deficiency (GHD). Objectives: To determine the optimal somavaratan dose regimen to normalize IGF-1 in pediatric GHD and to
Autor:
Gad B Kletter, Richard M. Sherry, Diana Ovejero Crespo, Clara C. Chen, Alison M. Boyce, Lori C. Guthrie, Andrew J. Dwyer, William H. Chong, Richard Chang, Diala El-Maouche, Felasfa M. Wodajo, James C. Reynolds, Marilyn H. Kelly, Panagiota Andreopoulou, Nisan Bhattacharyya, Michael T. Collins, Rachel I Gafni
Publikováno v:
Journal of Bone and Mineral Research. 28:1386-1398
Tumor-induced osteomalacia (TIO) is a rare disorder of phosphate wasting due to fibroblast growth factor-23 (FGF23)-secreting tumors that are often difficult to locate. We present a systematic approach to tumor localization and postoperative biochemi
Autor:
Emilia M. Pinto, Jesse J. Jenkins, Gad B. Kletter, Jinling Wang, John P. Lawrence, Raul C. Ribeiro, Lisa M. McGregor, Richard W. Kriwacki, Sheila A. Shurtleff, Gerard P. Zambetti
Publikováno v:
Familial Cancer
Childhood adrenocortical tumor (ACT), a very rare malignancy, has an annual worldwide incidence of about 0.3 per million children younger than 15 years. The association between inherited germline mutations of the TP53 gene and an increased predisposi
Autor:
Peter A. Lee, Gad B. Kletter, William Gray, Erica A. Eugster, Edward O. Reiter, Lawrence A. Silverman, Paul Saenger, Dorothy I. Shulman, Lisa Flood, David Tierney, William L. Clarke, E. Kirk Neely
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 92:1697-1704
GnRH analog (GnRHa) therapy for central precocious puberty (CPP) typically involves im injections. The histrelin implant is a new treatment that provides a continuous slow release of the GnRHa histrelin.The objective of the study was to investigate t
Autor:
Katherine Lewis, E. Kirk Neely, Erica A. Eugster, Surya Chitra, Oksana Terleckyj, Lawrence A. Silverman, Gad B. Kletter
Publikováno v:
The Journal of clinical endocrinology and metabolism. 100(6)
Context and Objective: The histrelin implant has proven to be an effective method of delivering GnRH analog (GnRHa) therapy to children with central precocious puberty (CPP), yet there are limited data available regarding hormonal suppression and aux
Publikováno v:
Pediatric and Developmental Pathology. 5:54-68
Congenital absence of the midbrain and upper pons is a rare human malformation. We describe two unrelated infants with this anomaly and cerebellar hypoplasia who were born at term but died in early infancy from lack of central respiratory drive. MRI
Publikováno v:
Clinical pediatrics. 54(5)
Autor:
Vasantha Padmanabhan, Carol M. Foster, Wensheng Guo, Ayse Pinar Cemeroglu, Robert P. Kelch, John C. Marshall, Gad B. Kletter, Morton B. Brown
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 83:3501-3506
Estradiol (E2) negative feedback on LH secretion was examined in 10 pubertal girls, testing the hypothesis that E2 suppresses LH pulse frequency and amplitude through opioid pathways. At 1000 h, a 32-h saline infusion was given, followed 1 week later
Publikováno v:
European Journal of Pediatrics. 165:320-322
We report the case of a 23-month-old girl who presented with poor growth and delayed attainment of gross-motor milestones. Elevated creatine phosphokinase (CPK) indicated rhabdomyolysis, ultimately attributed to severe, acquired autoimmune hypothyroi